Despite meningitis outbreak, some hospitals have little choice but to rely on compounding pharmacies. Many hospitals will continue to use compounding pharmacies for hard-to-obtain drugs because they have no alternative, even though a deadly meningitis outbreak traced to a compounding facility has raised grave concerns about safety and oversight.
As of Oct. 12, at least 184 people in 12 states had contracted fungal meningitis after receiving tainted steroid injections from the New England Compounding Center, according to the Centers for Disease Control and Prevention. Fourteen had died.
Read the full story: http://bit.ly/QHq9Oa
Source: Modern Healthcare